Kenichi Katsurada

Suggest Changes

Writes About:

Learn More
Glucagon-like peptide-1 (GLP-1) receptor agonists have been used to treat type 2 diabetic patients and shown to reduce food intake and body weight. The anorexigenic effects of GLP-1 and GLP-1(More)
  • 1